⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 2, 2024The OncologistOpen Access

Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center

Angelos Angelakas T Christodoulou Konstantinos Kamposioras Jorge Barriuso Michael Braun Jurjees Hasan Francisca M. Marti Vivek Misra Saifee Mullamitha Mark Saunders Natalie Cook

View Full Paper

Ask AI

Bookmark

Share

Abstract

Early onset Colorectal Cancer (EOCRC), defined as those diagnosed under the age of 50, has been increasing rapidly since 1970. UK data on EOCRC are currently limited and better understanding of the condition is needed.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Angelakas et al. (2024) studied this question.

synapsesocial.com/papers/68e55ef0e2b3180350efc49e https://doi.org/10.1093/oncolo/oyae239

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1[Emphasis on awareness of early-onset colorectal cancer].2024
2Research Progress in Early-onset Colorectal Cancer2024 · 1 citations
3Exploring Demographic Differences and Outcomes in Early-Onset Colorectal Cancer2024 · 8 citations
4Early-onset colorectal cancer: a comprehensive review reframing hypotheses and defining research prioritiesNarrative Review · 2026 · 2 citations
5Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers2024 · 35 citations

More related papers

Announcing The Lancet Regional Health—Europe series on the alarming surge of early-onset colorectal cancer: a multidisciplinary call to action2026
Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling2026
The adverse outcomes and progressive nature of early-onset colorectal cancer2026

More from The Oncologist

From Efficacy to Effectiveness in Gynecologic Oncology: Social Determinants, Therapeutic Transportability, and Biological WeatheringTue,
Real-World Comparative Effectiveness of FOLFOX, FOLFIRI, and CapOx as Second-Line Chemotherapy for Advanced Biliary Tract CancerWed,